Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)
Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc
University of Pittsburgh
Princess Maxima Center for Pediatric Oncology
Novartis
University of Virginia
LaNova Medicines Limited
Alliance Foundation Trials, LLC.
Karyopharm Therapeutics Inc
Erasca, Inc.
University College, London
NKGen Biotech, Inc.
Royal Marsden NHS Foundation Trust
Southwest Hospital, China
Hadassah Medical Organization
INSYS Therapeutics Inc
La Jolla Pharmaceutical Company
M.D. Anderson Cancer Center